(Q33766720)

English

Induced and pre-existing anti-polyethylene glycol antibody in a trial of every 3-week dosing of pegloticase for refractory gout, including in organ transplant recipients

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Induced and pre-existing anti-polyethylene glycol antibody in a trial of every 3-week dosing of pegloticase for refractory gout, including in organ transplant recipients (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

1 reference

based on heuristic

inferred from title

author name string

Michael S Hershfield

1

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Nancy J Ganson

2

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Susan J Kelly

3

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Edna L Scarlett

4

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Denise A Jaggers

5

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

John S Sundy

6

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

publication date

7 March 2014

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Arthritis Research and Therapy

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

16

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

R63

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

PEGylated drugs in rheumatology--why develop them and do they work?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4060462

22 June 2018

The immunogenicity of polyethylene glycol: facts and fiction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4060462

22 June 2018

Long-term safety of pegloticase in chronic gout refractory to conventional treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4060462

22 June 2018

Role of the methoxy group in immune responses to mPEG-protein conjugates

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4060462

22 June 2018

Efficacy and tolerability of pegloticase for the treatment of chronic gout in patients refractory to conventional treatment: two randomized controlled trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4060462

22 June 2018

Treating gout with pegloticase, a PEGylated urate oxidase, provides insight into the importance of uric acid as an antioxidant in vivo

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4060462

22 June 2018

A critical reappraisal of allopurinol dosing, safety, and efficacy for hyperuricemia in gout

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4060462

22 June 2018

Long-term cardiovascular mortality among middle-aged men with gout

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4060462

22 June 2018

Control of hyperuricemia in subjects with refractory gout, and induction of antibody against poly(ethylene glycol) (PEG), in a phase I trial of subcutaneous PEGylated urate oxidase

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4060462

22 June 2018

Effect of pegylation on pharmaceuticals

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4060462

22 June 2018

Quality of life and disability in patients with treatment-failure gout.

1 reference

https://api.crossref.org/works/10.1186%2FAR4500

21 January 2018

Gout in solid organ transplantation: a challenging clinical problem

1 reference

https://api.crossref.org/works/10.1186%2FAR4500

21 January 2018

Reduction of plasma urate levels following treatment with multiple doses of pegloticase (polyethylene glycol-conjugated uricase) in patients with treatment-failure gout: results of a phase II randomized study

1 reference

https://api.crossref.org/works/10.1186%2FAR4500

21 January 2018

Population pharmacokinetic and pharmacodynamic analysis of pegloticase in subjects with hyperuricemia and treatment-failure gout

1 reference

https://api.crossref.org/works/10.1186%2FAR4500

21 January 2018

Independent and conjoint associations of gout and hyperuricaemia with total and cardiovascular mortality

1 reference

https://api.crossref.org/works/10.1186%2FAR4500

21 January 2018

Tophaceous gout and high level of hyperuricaemia are both associated with increased risk of mortality in patients with gout.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4060462

30 October 2018

Gout medication treatment patterns and adherence to standards of care from a managed care perspective

1 reference

https://pubmed.ncbi.nlm.nih.gov/24602182

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics and pharmacodynamics of intravenous PEGylated recombinant mammalian urate oxidase in patients with refractory gout

1 reference

https://pubmed.ncbi.nlm.nih.gov/24602182

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Independent impact of gout on mortality and risk for coronary heart disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/24602182

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum Uric Acid and Risk of Cardiovascular Mortality: A Prospective Long-Term Study of 83 683 Austrian Men

1 reference

https://pubmed.ncbi.nlm.nih.gov/24602182

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum uric acid is an independent predictor for all major forms of cardiovascular death in 28,613 elderly women: A prospective 21-year follow-up study

1 reference

https://pubmed.ncbi.nlm.nih.gov/24602182

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33766720&oldid=2195760979"